This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Aralen (Chloroquine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (3)
Disability (2)
Reports by Reaction Type
Cataract (2),
Anaemia (2),
Vision Blurred (2),
Type 2 Diabetes Mellitus (1)
Possible Aralen side effects in 53 year old female
Reported by a consumer/non-health professional from Mexico on 2012-06-29
Patient: 53 year old female, weighing 75.0 kg (165.0 pounds)
Reactions: Type 2 Diabetes Mellitus
Drug(s) suspected as cause:
Aralen
Other drugs received by patient: Methotrexate
Possible Aralen side effects in 53 year old female
Reported by a consumer/non-health professional from Mexico on 2012-04-11
Patient: 53 year old female, weighing 71.0 kg (156.2 pounds)
Reactions: Cataract, Anaemia, Vision Blurred
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Aralen
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
Deflazacort
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
Arava
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
Methotrexate
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2007-01-01
Possible Aralen side effects in 53 year old female
Reported by a consumer/non-health professional from Mexico on 2012-03-23
Patient: 53 year old female, weighing 71.0 kg (156.2 pounds)
Reactions: Cataract, Anaemia, Vision Blurred
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Deflazacort
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
Methotrexate
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2007-01-01
Arava
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
Aralen
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
|